Delta-like 4 (Delta-4), a protein encoded by the DLL4 gene, is a crucial component of the Notch signaling pathway, a highly conserved cell signaling system that plays fundamental roles in various developmental processes and tissue homeostasis. Notably, Delta-4 functions as a ligand for Notch receptors, including Notch1 and Notch4, facilitating their activation upon binding. The interaction between Delta-4 and Notch receptors triggers a cascade of intracellular events, ultimately leading to the release of the Notch intracellular domain (NICD) through sequential proteolytic cleavage. Once released, NICD translocates to the nucleus, where it forms a transcriptional activation complex with other co-factors, such as Mastermind-like proteins, and regulates the expression of downstream target genes involved in cell fate determination, differentiation, proliferation, and survival.
Activation of Delta-4 occurs through various mechanisms that predominantly involve post-translational modifications and intracellular trafficking events. One of the primary modes of Delta-4 activation involves glycosylation, a process in which sugar molecules are added to the protein, enhancing its stability and binding affinity to Notch receptors. Additionally, proteolytic cleavage of Delta-4 by specific enzymes, such as Furin, may generate active forms of the protein capable of effectively engaging Notch receptors. Furthermore, intracellular trafficking processes, including endocytosis and exocytosis, contribute to the proper localization and presentation of Delta-4 on the cell surface, ensuring efficient Notch receptor activation. The tight regulation of Delta-4 activation is essential for the precise control of Notch signaling dynamics, which is critical for embryonic development, tissue morphogenesis, and adult tissue homeostasis in multicellular organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A γ-secretase inhibitor that might indirectly increase DLL4 levels by altering Notch signaling dynamics. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor that can influence gene expression, potentially affecting DLL4 levels. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, potentially influencing DLL4 through Wnt/β-catenin signaling pathways. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX (BIO) indirectly affects DLL4 expression by modulating Wnt/β-catenin signaling. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-β signaling, possibly influencing DLL4 expression. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $107.00 $156.00 | 4 | |
Another TGF-β signaling inhibitor, potentially influencing DLL4 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, might affect DLL4 expression through cell growth and proliferation pathways. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
An FGFR inhibitor, which might have an indirect impact on DLL4 expression in certain cellular contexts. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $63.00 $98.00 | 36 | |
A potent FGFR1 inhibitor, potentially affecting DLL4 indirectly | ||||||